Barnett Eva Renee
SEC CIK 1883766 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | CFO | 396.8K | — | $3.07M | 30 | 2021-10-04 | 2025-04-16 |
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Barnett Eva Renee made no open-market trades at IMVT in the last 12 months.
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | 2025-04-16 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $14.89 | -2,993 | 396.8K | -0.7% | -$44.6K | |
| M | 2025-04-11 | 2025-04-09 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $12.99 | -11.1K | 399.8K | -3% | -$143.7K |
| D | 2025-04-03 | 2025-04-01 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | A - Grant | $0.00 | +88.9K | 410.8K | +28% | $0 |
| 2025-02-21 | 2025-02-19 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $20.86 | -2,814 | 322.0K | -0.9% | -$58.7K | |
| M | 2025-01-17 | 2025-01-15 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $23.83 | -2,298 | 324.8K | -0.7% | -$54.8K |
| 2025-01-10 | 2025-01-08 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $24.10 | -4,105 | 327.1K | -1% | -$98.9K | |
| 2024-11-22 | 2024-11-20 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $25.45 | -4,174 | 331.2K | -1% | -$106.2K | |
| 2024-10-18 | 2024-10-16 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $28.79 | -3,271 | 335.3K | -1.0% | -$94.2K | |
| 2024-10-11 | 2024-10-09 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $29.56 | -5,162 | 338.6K | -2% | -$152.6K | |
| M | 2024-08-23 | 2024-08-21 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $31.86 | -3,768 | 343.8K | -1% | -$120.0K |
| M | 2024-07-19 | 2024-07-17 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $29.69 | -3,123 | 347.7K | -0.9% | -$92.7K |
| 2024-07-10 | 2024-07-09 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $28.06 | -4,747 | 350.7K | -1% | -$133.2K | |
| 2024-05-24 | 2024-05-22 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $29.65 | -4,042 | 355.4K | -1% | -$119.8K | |
| M | 2024-04-19 | 2024-04-17 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $29.06 | -12.3K | 359.5K | -3% | -$356.0K |
| 2024-04-10 | 2024-04-09 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $31.18 | -3,689 | 371.7K | -1.0% | -$115.0K | |
| D | 2024-04-04 | 2024-04-02 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | A - Grant | $0.00 | +55.0K | 375.4K | +17% | $0 |
| 2024-02-23 | 2024-02-22 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $36.15 | -2,930 | 320.4K | -0.9% | -$105.9K | |
| M | 2024-01-12 | 2024-01-11 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $41.83 | -3,515 | 323.4K | -1% | -$147.0K |
| M | 2023-11-24 | 2023-11-22 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $32.78 | -4,055 | 327.0K | -1% | -$132.9K |
| 2023-10-11 | 2023-10-10 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $36.92 | -4,557 | 330.9K | -1% | -$168.2K | |
| M | 2023-08-25 | 2023-08-24 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $20.30 | -14.4K | 335.5K | -4% | -$292.0K |
| 2023-07-20 | 2023-07-19 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $24.94 | -2,725 | 349.9K | -0.8% | -$68.0K | |
| 2023-04-19 | 2023-04-18 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $15.27 | -3,423 | 352.6K | -1.0% | -$52.3K | |
| D | 2023-04-14 | 2023-04-12 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | A - Grant | $0.00 | +87.7K | 356.0K | +33% | $0 |
| M | 2023-01-13 | 2023-01-11 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $16.75 | -4,510 | 272.8K | -2% | -$75.5K |
| 2022-10-13 | 2022-10-11 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $9.44 | -12.5K | 272.9K | -4% | -$118.0K | |
| D | 2022-08-19 | 2022-08-17 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | A - Grant | $0.00 | +112.8K | 285.4K | +65% | $0 |
| 2022-01-11 | 2022-01-07 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | S - Sale | $7.25 | -30.0K | 172.5K | -15% | -$217.2K | |
| D | 2021-10-18 | 2021-10-15 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | A - Grant | $0.00 | +143.0K | 202.5K | +240% | $0 |
| 2021-10-05 | 2021-10-04 | IMVT | Immunovant, Inc. | Barnett Eva Renee | CFO | A - Grant | $0.00 | +59.5K | 59.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations